Nuclear Medicine/Radiopharmaceutic Market - Global Outlook and Forecast 2024-2031

This report contains market size and forecasts of Nuclear Medicine/Radiopharmaceutic in global, including the following market information:
Global Nuclear Medicine/Radiopharmaceutic Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Nuclear Medicine/Radiopharmaceutic Market Sales, 2016-2021, 2022-2027, (Kiloton)
Global top five Nuclear Medicine/Radiopharmaceutic companies in 2020 (%)
The global Nuclear Medicine/Radiopharmaceutic market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nuclear Medicine/Radiopharmaceutic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Medicine/Radiopharmaceutic Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kiloton)
Global Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, By Type, 2020 (%)
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other

Global Nuclear Medicine/Radiopharmaceutic Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kiloton)
Global Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, By Application, 2020 (%)
Diagnostic
Therapeutic

Global Nuclear Medicine/Radiopharmaceutic Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (Kiloton)
Global Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nuclear Medicine/Radiopharmaceutic revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Nuclear Medicine/Radiopharmaceutic revenues share in global market, 2020 (%)
Key companies Nuclear Medicine/Radiopharmaceutic sales in global market, 2016-2021 (Estimated), (Kiloton)
Key companies Nuclear Medicine/Radiopharmaceutic sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Jubilant Pharma
Nordion
Eli Lilly
SIEMENS
China Isotope & Radiation
Yantai Dongcheng Biochemicals